Pacific Edge shares soar on hope for US market

Shares in cancer diagnostics company Pacific Edge soared on news that the American Urological Association has included Cxbladder Triage in its clinical guideline for caring for patients with microscopic traces of blood in the urine. By early afternoon, the stock was up 115% to 14 cents. The company said it anticipates an “uplift in demand for Cxbladder tests as more clinicians in the US and around the world begin to observe this updated guideline".More importantly, it also hopes to leverage the decision in its ongoing polic...